TYZAVAN
Live / Registered — Registered (as of 27 Jan 2026)
What this means for you
Registered since 27 Jan 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98113173
- Registration number
- 8119213
- Mark type
- Stylized text
- Filed
- 02 Aug 2023
- Published for opposition
- 14 May 2024
- Registered
- 27 Jan 2026
- Attorney of record
- Deborah L. Corpus
Goods and services
- Class 005 — Pharmaceuticals: Anti-infective, injectable pharmaceutical products in liquid finished dosage form for use in hospitals and clinics or by home health care professionals
Owner
- HIKMA PHARMACEUTICALS USA INC., BERKELEY HEIGHTS, NJ, US
- HIKMA PHARMACEUTICALS USA INC., BERKELEY HEIGHTS, NJ, US
- Xellia Pharmaceuticals ApS, Copenhagen S, DK
- Xellia Pharmaceuticals ApS, Copenhagen S, DK
Prosecution history
- 28 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Jan 2026 — TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
- 28 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 28 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 27 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
- 06 Jan 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Jan 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Jan 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Dec 2025 — USE AMENDMENT FILED
- 30 Dec 2025 — TEAS STATEMENT OF USE RECEIVED
- 08 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Jul 2025 — SOU EXTENSION 2 GRANTED
- 07 Jul 2025 — SOU EXTENSION 2 FILED
- 07 Jul 2025 — SOU TEAS EXTENSION RECEIVED